Pune: The long-term follow-up of more than 1,000 people from Pune, which has recovered from Covid, shows that REFFECTION After rare recovery and natural immunity after the disease can last a long time.
Research (still in pre-print) by epidemiologists and community medical experts from DY Patil Medical College and the hospital tracked 1,081 residents from the Metropolitan Pune region (PMR) from last September – when they showed SARS-COV-2 antibodies during Sero.
Survey – Until June this year.
Direct: Coronavirus Pandemicony 13 of 1,081 study participants continued to test positive Covid again for nine months of study – 1.2% reinfection rate, research was found.
Importantly, Covid’s second fight in all 13 is light and they proceed to fully recover.
Also read: post-vaccination errors that put you at the risk of reinfectiexperts say such research has important implications for countries that have a high number of Covid cases but limited supplies of vaccines.
By providing priority jabs to those who have not contracted Covid – people without natural immunity – the government can achieve immune flocks faster, at a minimum cost, they said.
“The point is, considering the level of low reinfection, people who have recovered from natural infections must be behind the queue in vaccination programs,” said the clinical epidemiology and study premier investigators, Amitav Banerjee.
Sero Survey reports from various parts of the country, including the latest from PMR, showing IgG antibodies at 70-80% of the population.
“So, we must first target 20-30% of the remaining people, which will save a lot of resources and, at the same time, help achieve the immunity of the population level 100%,” said Banerjee.
Regarding the possibility of the third wave, Banerjee said, “Given the seropocytic level of almost 80% in the population after the second wave, we should not expect this third wave this year.” Commenting on Pune Studies, Epidemiology based in Delhi Sanjay Rai, Professor of Community Medicine in AIIMS, said, “The evidence shown here is in line with the evidence available from global studies.” Sanjay Pujari’s infectious expert, member of the National Task Force in Covid-19 said, “The results are in line with the data that arises about reinfection from all over the world.
Reinfection is rare between those who have recovered from Covid-19.” More research is needed to Accurately determine the risk of reinfection, especially in the context of a new variant.
“Until more data is available, recovery individuals need to comply with the appropriate behavior for covid and vaccinate in time,” Pujari said.
Rare reinfection, eternal immunity to those who signed Covid-19: Study
